• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Comput Biol . Different antigenic distance metrics generate similar predictions of influenza vaccine response breadth despite moderate correlat

tetano

Editor, Senior Moderator
PLoS Comput Biol


. 2025 Nov 14;21(11):e1013720.
doi: 10.1371/journal.pcbi.1013720. Online ahead of print. Different antigenic distance metrics generate similar predictions of influenza vaccine response breadth despite moderate correlation

W Zane Billings[SUP] 1 2 [/SUP], Yang Ge[SUP] 1 [/SUP], Amanda L Skarlupka[SUP] 3 [/SUP], Savannah L Miller[SUP] 1 2 [/SUP], Hayley Hemme[SUP] 1 2 [/SUP], Murphy John[SUP] 1 2 [/SUP], Natalie E Dean[SUP] 4 [/SUP], Sarah Cobey[SUP] 5 [/SUP], Benjamin J Cowling[SUP] 6 [/SUP], Ye Shen[SUP] 1 [/SUP], Ted M Ross[SUP] 7 8 [/SUP], Andreas Handel[SUP] 1 2 [/SUP]



Affiliations
Abstract

Introduction: Influenza continuously evolves to escape population immunity, which makes formulating a vaccine challenging. Antigenic differences between vaccine strains and circulating strains can affect vaccine effectiveness (VE). Quantifying the antigenic difference between vaccine strains and circulating strains can aid interpretation of VE, and several antigenic distance metrics have been discussed in the literature. Here, we compare how the predicted breadth of vaccine-induced antibody response varies when different metrics are used to calculate antigenic distance.
Methods: We analyzed data from a seasonal influenza vaccine cohort that collected serum samples from 2013/14 - 2017/18 at three study sites. The data include pre- and post-vaccination HAI titers to the vaccine strains and a panel of heterologous strains. We used that data to calculate four different antigenic distance measures between assay strains and vaccine strains: difference in year of isolation (temporal), p-Epitope (sequence), Grantham's distance (biophysical), and antigenic cartography distance (serological). We analyzed agreement between the four metrics using Spearman's correlation and intraclass correlation. We then fit Bayesian generalized additive mixed-effects models to predict the effect of antigenic distance on post-vaccination titer after controlling for confounders and analyzed the pairwise difference in predictions between metrics.
Results: The four antigenic distance metrics had low or moderate correlation for influenza subtypes A(H1N1), B/Victoria, and B/Yamagata. A(H3N2) distances were highly correlated. We found that after accounting for pre-vaccination titer, study site, and repeated measurements across individuals, the predicted post-vaccination titers conditional on antigenic distance and subtype were nearly identical across antigenic distance metrics, with A(H1N1) showing the only notable deviation between metrics.
Discussion: Despite moderate correlation among metrics, we found that different antigenic distance metrics generated similar predictions about breadth of vaccine response. Costly titer assays for antigenic cartography may not be needed when simpler sequence-based metrics suffice for quantifying vaccine breadth.


 
Back
Top Bottom